Dronedarone for the treatment of atrial fibrillation and atrial flutter: approval and efficacy
Deborah Wolbrette, Mario Gonzalez, Soraya Samii, Javier Banchs, Erica Penny-Peterson, Gerald NaccarelliPenn State Heart and Vascular Institute, Penn State Milton S Hershey Medical Center, Hershey, Pennsylvania, USAAbstract: Dronedarone, a new Class III antiarrhythmic agent, has now been approved by...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-06-01
|
| Series: | Vascular Health and Risk Management |
| Online Access: | http://www.dovepress.com/dronedarone-for-the-treatment-of-atrial-fibrillation-and-atrial-flutte-a4675 |